EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Solid-variant primary pulmonary adenoid cystic carcinoma with pleural metastasis and malignant pleural effusion: a rare case report

Suyi Guo, Yang Zhai, Hongbian Gao, Caixia Ding

Frontiers in Oncology · 18.05.2026 · 16

DOI: 10.3389/fonc.2026.1827108 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 18.05.2026. Verfasst von Suyi Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi University of Chinese Medicine, Xianyang, China. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary adenoid cystic carcinoma (PACC) is a rare salivary gland-type malignancy, accounting for 0.04%–0.2% of primary lung neoplasms. The solid variant with pleural metastasis and malignant pleural effusion is exceptionally uncommon, posing significant diagnostic and therapeutic challenges. Case presentation We report a 65-year-old man whose lung biopsy was initially interpreted as squamous cell carcinoma without keratinization in the setting of basaloid morphology and p40/p63 positivity. The diagnosis was revised to solid-variant primary PACC after an expanded immunohistochemical workup demonstrated biphasic epithelial–myoepithelial differentiation, including expression of SOX10 and c-Myb. Given the advanced stage, the patient received a systemic combination of tislelizumab, cyclophosphamide, pegylated liposomal doxorubicin, and nedaplatin, initially combined with local intrapleural therapy. This treatment was followed by a partial response and marked symptomatic improvement without grade ≥3 treatment-related adverse events.

Conclusion

This case highlights a diagnostic pitfall in lung tumors exhibiting squamoid immunophenotypes and underscores the necessity of incorporating myoepithelial markers into the diagnostic workup. Furthermore, it provides a cautiously interpreted clinical observation of immune checkpoint inhibitor–based combination therapy in advanced PACC.

Schlagwörter

Stichwörter der Autor:innen

CAP-like chemoimmunotherapySOX10diagnostic challengeimmune checkpoint inhibitorpleural metastasisprimary pulmonary adenoid cystic carcinomasolid-variant

Autor:innen und Institutionen

  • Shaanxi University of Chinese Medicine, Xianyang, China.
  • Department of Medical Oncology, Shaanxi Provincial Cancer Hospital, Xi'an, China.
  • Department of Pathology, Shaanxi Provincial Cancer Hospital, Xi'an, China.

Zitieren

APA

Guo, S., Zhai, Y., Gao, H., & Ding, C. (2026). Solid-variant primary pulmonary adenoid cystic carcinoma with pleural metastasis and malignant pleural effusion: a rare case report. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1827108

Vancouver

Guo S, Zhai Y, Gao H, Ding C. Solid-variant primary pulmonary adenoid cystic carcinoma with pleural metastasis and malignant pleural effusion: a rare case report. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1827108

BibTeX
@article{Guo2026,
  author = {Guo, Suyi and Zhai, Yang and Gao, Hongbian and Ding, Caixia},
  title = {Solid-variant primary pulmonary adenoid cystic carcinoma with pleural metastasis and malignant pleural effusion: a rare case report},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1827108}
}
Kostenlos starten →